Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

CONQUER trial reveals benefits of phentermine/topiramate combination in obesity

Sep. 30, 2010

Clinical data presented on DiaPep-277 in type 1 diabetes

Sep. 30, 2010

Nycomed submits European filing for marketing approval of EX-101

Sep. 29, 2010

Imeglimin shows promise in phase II trials in type 2 diabetes

Sep. 29, 2010

Phase II data on MK-0941 cast doubt on suitability for treatment of diabetes

Sep. 29, 2010

FDA accepts Bionovo's manufacturing plan for Menerba

Sep. 28, 2010

Phenex Pharma receives financing for FXR and RORgt R&D programs

Sep. 28, 2010

Rosiglitazone-containing diabetes medicines suspended in Europe, restricted in U.S.

Sep. 28, 2010

New oral contraceptive Beyaz receives FDA approval

Sep. 28, 2010

New dual GLP-1/glucagon receptor agonists described

Sep. 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...